Medipharm Labs Corp T.LABS

Reposted - may explain the large BID versus ASK

[prone]

-->" I don't post garbage.  They are facts that Pfizer and USC Keck have been working together since 2013 and Pfizer has exclusive option to start clinical trials on anything promising.   

Then Medipharm joined the picture in 2015.   
In 2023 Medipharm shipped clinical trial material to USC Keck with approval by the DEA and funded by the NIH.   

But what I see is there are a handful of people on this board who think they run it and want to control the narrative and keep things in a negative tone by 'bashing' other posters.   

 

I'm still very optimistic that this company will show profits in October reporting and maybe a reason why they suddenly payed off the last piece of debt.   

 

If you have facts to bring to this forum then that's great but don't bash other people because it makes you look desperate instead of fact based investor. " 

[Solid1]

Where can you see that Pfizer has any exclusive rights to research and studies? There must be some news about this 

[newbie101abc]

This post has been removed in accordance with Community Policy

[Lemoyne]

This is why this board is so bad. People posting and reposting garbage. 1. Those 2013 news are the result of a person diving head first in a rabbit hole trying to find value where there is none. And some of the information in that post underscores the OG poster disability to do decent due diligence. You don't have to search deep to find out that LABS has a history of posting news concerning

[QContinuum1]

An intelligent and reasonable retort.

[Solid1]

Stada at least had the size to push through the necessary reforms in Germany... the removal from the narcotics list and now the abolition of the health insurance reservation And the preference for finished drugs plays into the hands of companies like Medipharm labs and Stada... Big Pharma... this deal already has weight - just don't panic 

[QContinuum1]

You're making alot of assumptions and excuses on behalf of Stada.  We have been told they are #2 in oils in Germany and yet that status doesn't appear to benefit Medipharm at all.  I'm sure Stada has the might to drive reforms, it's just not clear if they are pushing and driving sales as our most important partner in Western Europe.  Something with the Stada

[Solid1]

the trend is moving in the direction of finished medicinal products. The DEA and FDA, the health authorities in Germany, etc. Will agree on exactly that... simple quality monitoring and regulation. What is missing are completed studies, but they will come. And companies like Stada have absolutely no problems selling such drugs... everything is going just right why such a bad mood? 

[QContinuum1]

I am not in a bad mood, I am simply expecting more.  I do not agree that all is well and that things are moving positively.  You are making sweeping assumptions that Medipharm will benefit from any of the things you speak of and that, at some point, trials and drugs will come.  There is no indication that any of that will happen in the immediate or medium term and no drugs are late

[Solid1]

https://www.newswise.com/articles/clinical-trial-shows-synthetic-cannabis-reduces-agitation-in-alzheimer-s-disease

[QContinuum1]

Lovely.  Where is the purchase order?

[QContinuum1]

In case anyone is interested: Clinical Trial Number: NCT02792257 Phase II, so a very LONG way to go.

[okgonow]

well we dontbproduce Synthetic ingriedients forn drobinol we only supply the real stuff so you have to nre runn the study with the stuff we make the FDA is pretty sticky when it comes to whats in a aproved drug you cant just put th natural stuff in and say its the same .....they will want a full trial done for aproval

[QContinuum1]

It's nonsensical that someone would post such a thing as 'positive' relating to Medipharm in any case.  It's Phase II and miles away from seeing prime time.  Just like the 'Entropy-Master', anyone can post positive things about cannabis in medicine all day long, but none will benefit Medipharm within the timeframes we want it to or within the timeframes of this

[Solid1]

  https://www.newswise.com/articles/clinical-trial-shows-synthetic-cannabis-reduces-agitation-in-alzheimer-s-disease

[QContinuum1]

In case anyone is interested: Clinical Trial Number: NCT02792257 Phase II, so a very LONG way to go.

[Solid1]

https://www.prnewswire.com/news-releases/medipharm-labs-reports-second-quarter-results-closing-in-on-positive-adjusted-ebitda1-as-gross-profit-continues-to-improve-302221470.html

[okgonow]

what i cant get my head arround is the endless amounts of .06 , .065 and .07 cent shares available just when you think we finally chewed thru the .07 a whole new crop of them shows... ok some may say our volumes are so low but after a month's + of trading in this range we cant seem to move .05 higher ?????? this is f'dddddddd

[QContinuum1]

Penny stock flippers